Advanced Prostate Cancer

Degarelix Monotherapy vs. Luteinizing Hormone-Releasing Hormone Agonists Plus Antiandrogen Flare Protection For Men With Advanced Prostate Cancer *

There are a number of different flavors of hormone therapy (ADT) used to treat advanced prostate cancer. However, they could be summed up and put into two different categories. 1- The use of luteinizing hormone-releasing hormone (LHRH) agonist therapy (drugs like Lupron and Zoladex) along with short term antiandrogen (AA) flare protection 2- Degarelix, a [...]

By |2020-02-04T11:51:33-05:00December 4th, 2014|ADT, Advanced Prostate Cancer, Androgan Receptor Inhibitor, degarelix, Drugs & Treatments, General Information, Hormone Therapy, Research, Uncategorized, Understanding APC|0 Comments
Read More

Dealing with A New Health Issue – A Rare Cancer Along with Prostate Cancer

My wife Wendy wrote a post to the advanced prostate cancer online support group where she discussed our recent experience re-entering the healthcare system to deal with a non-prostate cancer issue. In the post she shared that I have been diagnosed with a rare cancer, appendiceal cancer, specifically a mucinous cystadenocarcinoma. We have become very [...]

By |2020-02-04T08:42:28-05:00December 2nd, 2014|Advanced Prostate Cancer, advanced prostate cancer support group, Prostate Ponderings, survivorship, Uncategorized|0 Comments
Read More

Using choline-C11 PET/CT Scans To Predict Survival In Men With Recurrent Prostate Cancer

Choline-C11 PET/CT scans can identify the actual sites of recurrence of prostate cancer in men who have a rising PSA after receiving primary therapy. The question worth asking is if this type of scan might be able to be used for prognostic purposes. Knowing this might influence our treatment decisions as well as our basic [...]

By |2020-02-04T11:36:42-05:00November 28th, 2014|adjuvant therapy, Advanced Prostate Cancer, Choline C11, Scanning Technology, Uncategorized, Understanding APC|0 Comments
Read More

US Government Begins to Crack Down on Clinical Trials Reporting

Yes, it is true, many clinical trial results are not published, especially negative results. This is even true for FDA approved drugs and treatments! Failing to publish, or actually hiding negative results and harmful side effects that occur in clinical trials is too common and jeopardizes each and everyone of us, including survivors of advanced [...]

By |2020-02-04T11:06:19-05:00November 25th, 2014|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, FDA, General Information, NIH, Uncategorized|0 Comments
Read More

Where Have I been the Past Week?

Over this past week I have not been able to make any post to the blog. I apologize to anybody kept coming back to the blog and didn't see anything new. Two Sunday nights ago I was admitted to the hospital and had an emergency appendectomy the following Tuesday night. Due to my age and [...]

By |2017-10-19T10:47:42-04:00November 24th, 2014|Advanced Prostate Cancer, General Information, Prostate Ponderings, Uncategorized, Understanding APC|0 Comments
Read More

Nationwide Recall of Gabapentin for the Treatment of Hot Flashes Resulting from Hormone Therapy (ADT)

The drug Gabapentin is occasionally prescribed to help control hot flashes resulting from hormone deprivation therapy (ADT). Today, Aurobindo Pharma USA, Inc. issued a voluntary nationwide recall of their Northstar Labeled Gabapentin Capsules, USP 300 mg 100 count bottle. The recall was issued on complaints about empty capsules in prescriptions received by patients. There is [...]

By |2014-11-24T18:07:21-05:00November 24th, 2014|ADT, Advanced Prostate Cancer, Drug Recalls, Drugs & Treatments, FDA, Gabapentin, Hot Flashes|0 Comments
Read More

Radiotherapy Should Be Added to Hormone Therapy in Node-Positive Prostate Cancer as the New Standard of Care

In the normal course of events node-positive prostate cancer has typically been excluded from clinical trials. This leaves our oncologists with little evidence to guide the management for those of us who have this flavor of prostate cancer. A recent anaylisis presented at the European Society for Medical Oncology (ESMO) 2014 Congress begins to shed [...]

By |2020-02-04T10:48:26-05:00November 13th, 2014|ADT, Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, ESMO, Uncategorized, Understanding APC|0 Comments
Read More

Bone Complications Among Prostate Cancer Survivors Having Prolonged Hormone Therapy (ADT)

Androgen deprivation therapy (ADT) and bone complications are the two near universals for men with advanced prostate cancer. A long-term follow up of fifteen (15) years after diagnosis of a population-based cohort of prostate cancer survivors proved to be very informative. The Prostate Cancer Outcomes Study, which enrolled 3533 men diagnosed with prostate cancer between [...]

By |2020-02-04T08:42:24-05:00November 12th, 2014|ADT, Advanced Prostate Cancer, Bone Health, Drugs & Treatments, Hormone Therapy, Uncategorized, Understanding APC|0 Comments
Read More

Xofigo To Again Be Available to New Patients with Metastatic Prostate Cancer

Bayer Healthcare has announced that they will be resuming production of Xofigo® (radium Ra 223 dichloride) for new patients beginning on Monday, November 17th. Xofigo is the newly FDA approved radiopharmaceutical treatment for men with castrate resistant metastatic prostate cancer (mCRPC) with bone metastases without any known visceral metastases. On October 8, 2014 Bayer informed [...]

By |2014-11-11T16:04:45-05:00November 11th, 2014|Advanced Prostate Cancer, Bone Metastases, Drugs & Treatments, radiopharmaceuticals, Uncategorized, Xofigo|0 Comments
Read More
Go to Top